Four years after its approval in the United States, transcatheter aortic valve replacement (TAVR) continues to evolve and demonstrate positive outcomes for patients with aortic stenosis, a common heart problem, according ...
Nov 30, 2015
0
5
Two-year data reveal no difference in the combined rate of stroke and death from any cause when comparing the use of self-expanding transcatheter aortic valve replacement (TAVR) with standard open-heart surgery in intermediate ...
Mar 17, 2017
0
0
The diagnosed severity of aortic stenosis strongly correlates with clinical outcomes, new Kaiser Permanente research published in the American Heart Journal shows. But the study also suggests that fine-tuning physician assessment ...
Sep 5, 2023
0
6
The first one-year outcomes data of transcatheter heart valve replacement (TAVR) in nearly all U.S. patients undergoing this procedure shows that real-world outcomes are comparable to or slightly better than those found in ...
Mar 31, 2014
0
0
Additional analysis from the SMall Annuli Randomized To Evolut or SAPIEN (SMART) study demonstrated clinical non-inferiority of self-expanding valves (SEV) versus balloon-expandable valves (BEV) in aortic stenosis patients ...
May 3, 2024
0
10
Cardiologists failed to identify more than half of basic and about 35 percent of advanced pre-recorded murmurs, but skills improved after a 90 minute training session, according to research presented today at the European ...
Aug 31, 2015
0
9
Aug. 28 2017: Transcatheter aortic valve implantation (TAVI) is safe and effective in nonagenarians, according to research presented at ESC Congress today.1 The observational study found that nonagenarians who underwent TAVI ...
Aug 28, 2017
0
1
A first-ever randomized head-to-head comparison of two devices commonly used to treat the age-related disease aortic stenosis finds balloon-expandable transcatheter valves result in more successful procedures and relieve ...
Mar 31, 2014
0
0
A substudy of the PARTNER I Trial and Continued Access Registry found that hemodynamic trends in patients who received transcatheter aortic valve replacement (TAVR) showed excellent durability without significant structural ...
Nov 1, 2016
0
0
(HealthDay)—In an all-female transcatheter aortic valve replacement (TAVR) registry, 14.0 percent of women experienced a 30-day Valve Academic Research Consortium (VARC-2) composite safety end point, according to a study ...
May 19, 2016
0
0
